ERNA SCHEDULE 13G/A: SEC filing
Ernexa Therapeutics Inc.
Filed with the SEC on · accession 0001193125-26-441302
ERNA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 30, 2026. Ernexa Therapeutics Inc. filed an amended Schedule 13G indicating a passive institutional ownership position. The stock moved -6.6% by the first close after the filing.
Summary of the filing
Ernexa Therapeutics Inc. filed an amended Schedule 13G indicating a passive institutional ownership position. The filing text provided contains only EDGAR directory metadata and no substantive ownership details.
Key details
How ERNA stock reacted
Close before
$2.11
Oct 29, 2026
First close after
-6.64%
$1.97
5 trading days
-13.27%
$1.83
Since filing
-10.90%
$1.88
✦ Ask GOAX AI about this filing — what it means for ERNA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ERNA?
Click hereFrequently asked questions
What did ERNA file with the SEC on Oct 30, 2026?
ERNA filed a SCHEDULE 13G/A (SEC filing). Ernexa Therapeutics Inc. filed an amended Schedule 13G indicating a passive institutional ownership position. The filing text provided contains only EDGAR directory metadata and no substantive ownership details.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did ERNA stock react to this filing?
ERNA closed at $2.11 before the filing and $1.97 on Oct 30, 2026 (-6.64%). Five trading days later: $1.83 (-13.27%).
Other ERNA SEC filings
Get alerts when ERNA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days